Delcath(DCTH) - 2024 Q1 - Quarterly Results

Exhibit 99.1 Delcath Systems Reports First Quarter 2024 Results and Business Highlights Conference Call Today at 8:30am Eastern Time QUEENSBURY – May 14, 2024, Delcath Systems, Inc. (Nasdaq: DCTH) ("Delcath" or the "Company"), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today reported financial results and business highlights for the first quarter ended March 31, 2024. Recent Business Highlights During and since the first quarter, Delcath: "We ...